🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To study the Pharmacokinetics (PK) parameters of montelukast, flurbiprofen,...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02456844
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
PHRU Non-Network CRS
Start Date
2020-02-21
Trial ID
NCT03882177
Treatments Being Tested
The primary purpose of this study is to determine whether the treatment wit...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01254461
Treatments Being Tested
The survival of esophageal cancer and stomach cancer (EGC) at 5 years is le...
Status
Unknown
Location
Department Gastroenterology. Hospital Donostia
Start Date
2009-11
Trial ID
NCT01038154
Treatments Being Tested
The primary objective of this study is to evaluate the effect of filgotinib...
Status
Completed
Location
Prism Research, LLC
Start Date
2020-11-04
Trial ID
NCT04608344
Treatments Being Tested
Since people started taking HIV medications, illnesses related to AIDS have...
Status
Withdrawn
Location
UCLA CARE Center CRS (601)
Start Date
2011-11
Trial ID
NCT01515813
Treatments Being Tested
The investigator's propose to conduct an open-label randomized controlled t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT05251129
Treatments Being Tested
The purpose of this study is to evaluate the effect of two dose levels of J...
Status
Completed
Location
Multiple Locations
Start Date
2002-06
Trial ID
NCT00688896
This is a single center, open-label, prospective, investigation to quantify...
Status
Recruiting
Location
Children's Mercy Hospital
Start Date
2024-03-01
Trial ID
NCT06324396
This is an open-label, single sequence study that is being conducted to inv...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-12-16
Trial ID
NCT04425902